PDB35 COST-CONSEQUENCE ANALYSIS OF CSII VS. MDI:A CANADIAN PERSPECTIVE

Cost-effectiveness analysis of abciximab: a Canadian hospital perspective.

OBJECTIVE To assess the cost-effectiveness of abciximab therapy versus traditional practice in high-risk patients receiving percutaneous transluminal coronary angioplasty (PTCA) from a Canadian hospital perspective. DESIGN A predictive decision analytic model using published clinical and economic evaluations, as well as costs of medical care in Canada. SUBJECTS High-risk PTCA patients as de...

The cost of wound debridement: a Canadian perspective.

Debridement is integral to wound bed preparation by removing devitalised tissue, foreign material, senescent cells, phenotypically abnormal/dysfunctional cells (cellular burden) and bacteria sequestrum (biofilm). While the body of evidence to substantiate the benefits of debridement is growing, little is known about the cost-effectiveness of each debridement method. The purpose of this analysis...

Dynamic vs. Classical Consequence

The shift of interest in logic from just reasoning to all forms of information flow has considerably widened the scope of the discipline, as amply illustrated in Johan van Benthem’s recent book Logical Dynamics of Information and Interaction. But how much does this change when it comes to the study of traditional logical notions such as logical consequence? We propose a systematic comparison be...

Cost-Utility analysis of tissue plasminogen activator therapy for acute ischaemic stroke: a Canadian healthcare perspective.

BACKGROUND There are over 40000 ischaemic strokes annually in Canada, which result in significant morbidity, mortality and burden to the healthcare system. A recent, large clinical trial has evaluated tissue plasminogen activator (t-PA) intravenously for the treatment of acute ischaemic stroke with promising outcomes but with an increased risk of symptomatic intracranial haemorrhage. OBJECTIV...

Cost-Benefit Analysis in Canadian Securities Regulation